文献速递乳房整形与再造

美国区域外科医生竞争对乳房再造使用、费用与结局的影响

Impact of Regional Surgeon Competition on Use, Cost, and Outcomes of Breast Reconstruction in the United States.
PubMed 文献 · Plast Reconstr Surg · 2024-07-30

该研究基于2009至2020年MarketScan索赔数据开展回顾性横断面分析,用赫芬达尔-赫希曼指数衡量区域整形外科医生竞争程度。结果显示,与低竞争区域相比,中度竞争区域(OR 1.51)和竞争区域(OR 1.71)乳房再造率更高,患者自付费用分别降低67.38美元和113.06美元,但总费用、外科医生费用或机构费用与竞争程度无线性关联。

要点

  • 中度竞争区域乳房再造几率高于低竞争区域(OR 1.51,95%CI 1.37-1.66,P<0.001)。
  • 竞争区域乳房再造几率高于低竞争区域(OR 1.71,95%CI 1.58-1.86,P<0.001)。
  • 竞争区域患者自付费用较非竞争区域降低113.06美元(95%CI -137.00至-89.12,P=0.02)。

核心结论

  • 外科医生之间竞争程度越高,乳房再造的可及性越好,但费用无差异。

研究设计与样本

  • 回顾性横断面分析,使用2009至2020年MarketScan索赔数据。
  • 以赫芬达尔-赫希曼指数衡量大都会统计区内各外科医生乳房再造病例比例的平方和,评估市场集中度。
  • 采用多变量逻辑回归分析不同赫芬达尔-赫希曼指数下乳房再造率、结局与费用的差异。

主要发现

  • 乳房切除术后2年内接受乳房再造的几率:中度竞争区域 vs 非竞争区域 OR 1.51(95%CI 1.37-1.66,P<0.001);竞争区域 vs 非竞争区域 OR 1.71(95%CI 1.58-1.86,P<0.001)。
  • 患者自付费用:中度竞争区域较非竞争区域降低67.38美元(95%CI -88.65至-46.11,P=0.007);竞争区域较非竞争区域降低113.06美元(95%CI -137.00至-89.12,P=0.02)。
  • 总费用、外科医生费用或机构费用与市场竞争分层之间未发现线性关联。

临床怎么用

  • 作者认为,应用该证据可包括系统层面策略以加强护理协调,同时通过政策针对医院和医院系统等费用驱动因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast reconstruction following mastectomy is underused in the United States. Evidence suggests that more competitive hospital markets offer increased access to procedural care across specialties. This study aimed to determine the impact of regional plastic surgeon competition on use, outcomes, and cost of breast reconstruction following mastectomy for breast cancer. METHODS: The authors conducted a retrospective cross-sectional analysis using MarketScan claims data from 2009 to 2020. The Herfindahl-Hirschman Index, a measure of market concentration, was calculated using the sum of squares of the proportion of breast reconstruction cases performed by each surgeon in a metropolitan statistical area. Multivariable logistic regression was used to identify differences in rates, outcomes, and costs of reconstruction by the Herfindahl-Hirschman Index. RESULTS: Odds of receiving breast reconstruction within 2 years of mastectomy were higher for those in moderately competitive (OR, 1.51 [95% CI, 1.37 to 1.66]; P < 0.001) or competitive (OR, 1.71 [95% CI, 1.58 to 1.86]; P < 0.001) regions compared with noncompetitive regions. Patient out-of-pocket costs decreased when comparing moderately competitive regions with noncompetitive regions (-$67.38 [95% CI, -$88.65 to -$46.11]; P = 0.007), and decreased further when comparing competitive with noncompetitive regions (-$113.06 [95% CI, -$137.00 to -$89.12]; P = 0.02). No linear association between total, surgeon, or facility cost and market competition strata was identified. CONCLUSIONS: Greater competition among surgeons is associated with improved access to reconstructive surgery, but no difference in cost. Application of this evidence may include system-level strategies to bolster care coordination, while targeting drivers of cost, such as hospitals and hospital systems, through policy.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Fahmy JN, Nasser JS, Wu H, et al. Impact of Regional Surgeon Competition on Use, Cost, and Outcomes of Breast Reconstruction in the United States. Plast Reconstr Surg. 2024. PMID: 39085102. doi:10.1097/PRS.0000000000011669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。